Over the Counter Metformin Substitute: What Actually Works (and What Doesn't)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• No over-the-counter supplement replicates metformin's mechanism of action or has equivalent FDA-reviewed evidence for blood sugar control
• Berberine shows the strongest clinical signal (1.0% A1C reduction in meta-analysis) but works through different pathways and has significant GI side effects
• Alpha-lipoic acid, chromium, and cinnamon have weak or inconsistent evidence and should not replace prescription therapy
• The search for OTC metformin alternatives often reflects access barriers (cost, insurance, prescriber availability) rather than medical preference for supplements over prescription medication

Direct answer (40-60 words)

No true over-the-counter metformin substitute exists. Berberine is the most-studied supplement with blood sugar effects, reducing A1C by approximately 1.0% in clinical trials, but it works through different mechanisms than metformin and lacks FDA approval for diabetes treatment. Other supplements (alpha-lipoic acid, chromium, cinnamon) have weak or inconsistent evidence and should not replace prescription therapy without provider guidance.

Table of contents

1. Why people search for OTC metformin alternatives
2. What most articles get wrong about berberine as a metformin substitute
3. The mechanism comparison: how metformin actually works vs supplements
4. Berberine: the strongest evidence and why it's not equivalent
5. Alpha-lipoic acid, chromium, and cinnamon: what the data actually shows
6. The cost-access problem driving supplement searches
7. When supplements make sense and when they don't
8. The decision tree: should you try an OTC alternative?
9. What to do if you can't access or afford metformin
10. The GLP-1 question: are newer medications better alternatives?
11. FAQ
12. Sources

Why people search for OTC metformin alternatives

The search volume for "over the counter metformin substitute" reflects three distinct patient populations:

Population 1: Access barriers. Metformin requires a prescription. Patients without insurance, without a primary care provider, or in states with restrictive telehealth laws face real obstacles. A 30-day supply of generic metformin costs $4 to $15 with insurance but $25 to $80 without. For patients paying cash, an OTC supplement that costs $20 per month looks financially equivalent.

Population 2: Side effect intolerance. Metformin causes GI side effects (diarrhea, nausea, bloating) in 25% to 30% of patients during titration (Florez et al., Diabetes Care 2010). About 5% discontinue treatment because of persistent GI symptoms. These patients hope an OTC alternative will deliver blood sugar benefits without the bathroom urgency.

Population 3: Supplement preference. A subset of patients prefer "natural" interventions over prescription medications, often based on the belief that supplements have fewer side effects or are inherently safer. This belief is not supported by evidence (supplements are less regulated and have their own side effect profiles), but it drives purchasing behavior.

The problem is that none of these populations are well-served by the current supplement market. The supplements marketed as metformin alternatives either lack strong evidence, work through entirely different mechanisms, or have side effect profiles comparable to metformin itself.

What most articles get wrong about berberine as a metformin substitute

The most common error in published content on this topic is the claim that berberine is "nature's metformin" or a "natural metformin alternative." This framing appears in dozens of supplement marketing sites and health blogs and is misleading in three specific ways:

Error 1: Mechanism equivalence. Berberine and metformin both lower blood sugar, but through different pathways. Metformin primarily works by reducing hepatic glucose production via AMPK activation and complex I inhibition in the mitochondrial respiratory chain (Rena et al., Diabetologia 2017). Berberine activates AMPK but also modulates gut microbiota, inhibits alpha-glucosidase in the intestine, and affects insulin receptor expression (Yin et al., Metabolism 2008). The downstream effect (lower glucose) is similar, but the upstream mechanisms are not interchangeable.

Error 2: Evidence equivalence. Metformin has been studied in over 300 randomized controlled trials involving more than 100,000 patients. The UKPDS 34 trial (1998) established metformin as first-line therapy for type 2 diabetes with a 32% reduction in diabetes-related endpoints. Berberine's evidence base consists of approximately 15 to 20 small trials, most conducted in China, with sample sizes of 30 to 100 patients. A 2015 meta-analysis (Dong et al., Evidence-Based Complementary and Alternative Medicine) pooled 14 trials and found berberine reduced A1C by 1.0%, comparable to metformin in head-to-head comparisons within those studies. But the quality of evidence is not equivalent. The trials are smaller, shorter (12 to 16 weeks vs years), and lack the cardiovascular outcome data that makes metformin a guideline-recommended first-line agent.

Error 3: Safety equivalence. Berberine causes GI side effects (diarrhea, constipation, abdominal pain) in 20% to 35% of users, comparable to metformin's GI side effect rate (Yin et al., Metabolism 2008). It also interacts with CYP3A4 and P-glycoprotein, affecting the metabolism of dozens of common medications including statins, blood thinners, and immunosuppressants (Guo et al., Xenobiotica 2012). Metformin has a well-characterized interaction profile and decades of post-market surveillance. Berberine does not.

The accurate framing is: berberine is the most-studied supplement with demonstrated blood sugar-lowering effects, but it is not a drop-in replacement for metformin and should not be used as monotherapy for diagnosed diabetes without provider supervision.

The mechanism comparison: how metformin actually works vs supplements

Metformin's primary mechanism is reducing hepatic glucose production. The liver normally releases glucose into the bloodstream between meals to maintain blood sugar. In insulin resistance and type 2 diabetes, the liver overproduces glucose even when blood sugar is already elevated. Metformin suppresses this overproduction by:

1. Activating AMP-activated protein kinase (AMPK), a cellular energy sensor that shifts metabolism away from glucose production
2. Inhibiting mitochondrial complex I, which reduces ATP production and signals the liver to stop making glucose
3. Modestly improving insulin sensitivity in peripheral tissues (muscle, fat)

The result is a 1.0% to 1.5% reduction in A1C, a 25% to 30% reduction in fasting glucose, and modest weight loss (2 to 3 kg over 6 to 12 months) (Knowler et al., New England Journal of Medicine 2002).

Supplements work through different pathways:

Berberine activates AMPK (similar to metformin) but also:

• Alters gut microbiota composition, increasing short-chain fatty acid production
• Inhibits alpha-glucosidase in the small intestine, reducing carbohydrate absorption
• Increases insulin receptor expression in liver and muscle cells
• Reduces lipid synthesis in the liver

Alpha-lipoic acid is an antioxidant that may improve insulin sensitivity by reducing oxidative stress in insulin-signaling pathways. The evidence is weak and inconsistent (Akbari et al., Hormone and Metabolic Research 2018).

Chromium is a trace mineral that may enhance insulin signaling by improving insulin receptor function. Meta-analyses show small, inconsistent effects on glucose control, with larger effects in chromium-deficient populations (Suksomboon et al., Diabetes Technology & Therapeutics 2014).

Cinnamon contains polyphenols that may improve insulin sensitivity and slow gastric emptying. The evidence is contradictory, with some trials showing modest glucose reduction and others showing no effect (Allen et al., Annals of Family Medicine 2013).

None of these supplements replicate metformin's primary mechanism (hepatic glucose suppression via complex I inhibition). They may have additive effects when combined with metformin, but they are not substitutes.

Berberine: the strongest evidence and why it's not equivalent

Berberine is an alkaloid compound extracted from several plants including goldenseal, barberry, and Oregon grape. It has been used in traditional Chinese medicine for centuries, primarily for GI infections.

The modern evidence base for berberine in blood sugar control includes:

Study	Design	Dose	Duration	A1C reduction	Fasting glucose reduction
Yin et al., Metabolism 2008	RCT, N=36	500 mg 3x/day	3 months	1.0%	25 mg/dL
Zhang et al., Metabolism 2008	RCT, N=48	500 mg 2x/day	3 months	0.9%	30 mg/dL
Dong et al., Evidence-Based CAM 2015 (meta-analysis)	14 RCTs, N=1,068	500-1500 mg/day	8-16 weeks	1.0% (pooled)	28 mg/dL (pooled)

The A1C reduction is clinically meaningful and comparable to metformin within these studies. But three major limitations prevent berberine from being a true substitute:

Limitation 1: Lack of long-term outcome data. Metformin reduces cardiovascular events, all-cause mortality, and diabetes-related complications in long-term trials (UKPDS 34, 1998). Berberine has no cardiovascular outcome trials. We don't know if the glucose-lowering translates to reduced heart attacks, strokes, or kidney disease.

Limitation 2: High pill burden and GI side effects. Effective berberine dosing is 500 mg three times daily, taken with meals. That's three pills per day, compared to one or two metformin tablets. The GI side effect rate is 20% to 35%, similar to metformin. Patients switching from metformin to berberine to avoid GI side effects often find the side effects are comparable.

Limitation 3: Drug interactions. Berberine inhibits CYP3A4, CYP2D6, and P-glycoprotein, affecting the metabolism of statins, anticoagulants, immunosuppressants, and many other medications (Guo et al., Xenobiotica 2012). Patients on multiple medications need provider supervision to avoid interactions. Metformin has minimal drug interactions.

FormBlends clinical pattern: Among patients who contact us asking about berberine as a metformin alternative, the most common pattern is cost-driven. They're paying $60 to $80 per month for metformin without insurance and see berberine at $20 to $30 per month on Amazon. When we help them access generic metformin through cost-assistance programs or switch to a $4 generic program at major pharmacies, most prefer to stay on metformin. The smaller subset who genuinely prefer supplements often discontinue berberine within 8 to 12 weeks because of GI side effects or the three-times-daily dosing schedule. The clinical pattern suggests berberine is a second-choice option driven by access barriers, not a preferred therapeutic alternative.

Alpha-lipoic acid, chromium, and cinnamon: what the data actually shows

Alpha-lipoic acid (ALA) is an antioxidant studied primarily for diabetic neuropathy. A 2018 meta-analysis (Akbari et al., Hormone and Metabolic Research) pooled 12 trials and found ALA reduced fasting glucose by 11 mg/dL and A1C by 0.3%. The effect is small and inconsistent across studies. ALA is more promising for neuropathy symptoms than glucose control. Typical dose: 600 mg daily. Side effects: nausea, skin rash (5% to 10%).

Chromium picolinate is a trace mineral supplement marketed for blood sugar control and weight loss. A 2014 meta-analysis (Suksomboon et al., Diabetes Technology & Therapeutics) pooled 25 trials and found chromium reduced A1C by 0.5% in patients with diabetes, but only in populations with baseline chromium deficiency. In well-nourished populations (most U.S. adults), the effect was not statistically significant. Typical dose: 200 to 1,000 mcg daily. Side effects: headache, GI upset, rare reports of kidney damage at high doses.

Cinnamon contains polyphenols (cinnamaldehyde, cinnamic acid) that may improve insulin sensitivity. A 2013 meta-analysis (Allen et al., Annals of Family Medicine) pooled 10 trials and found cinnamon reduced fasting glucose by 24 mg/dL but had no significant effect on A1C. A 2020 Cochrane review found the evidence "low quality" and concluded cinnamon should not be recommended for diabetes management. Typical dose: 1 to 6 grams daily (roughly 1/2 to 2 teaspoons). Side effects: mouth sores, liver toxicity at high doses (cassia cinnamon contains coumarin, a hepatotoxin).

The pattern across all three supplements is the same: small, inconsistent effects that fall well short of metformin's 1.0% to 1.5% A1C reduction. None are appropriate as monotherapy for diagnosed diabetes.

The cost-access problem driving supplement searches

The real question behind "over the counter metformin substitute" is often: how do I manage my blood sugar when I can't access or afford prescription medication?

The cost barrier is real. Metformin is available as a $4 to $10 generic at Walmart, Kroger, and most major pharmacy chains, but only if you have a prescription. For patients without insurance and without a prescriber relationship, the cash price at CVS or Walgreens is $25 to $80 for a 30-day supply. Add the cost of a provider visit ($100 to $200 for a new patient appointment), and the total cost of starting metformin is $125 to $280 in month one.

Berberine costs $15 to $30 per month on Amazon or at supplement retailers. No prescription required. For a patient with prediabetes or early type 2 diabetes who is uninsured and doesn't have a regular provider, the economic logic is clear.

The problem is that this economic logic leads to suboptimal care. Berberine is not a substitute for metformin, and using it as monotherapy for diagnosed diabetes delays evidence-based treatment and increases the risk of complications.

The better solutions:

For prediabetes (A1C 5.7% to 6.4%): Lifestyle intervention (diet, exercise) is first-line and more effective than either metformin or supplements. The Diabetes Prevention Program (Knowler et al., New England Journal of Medicine 2002) showed intensive lifestyle intervention reduced diabetes incidence by 58% vs 31% for metformin. If lifestyle intervention isn't enough, metformin is the evidence-based next step, but berberine is a reasonable alternative if cost or access is prohibitive.

For diagnosed diabetes (A1C ≥ 6.5%): Prescription medication is necessary. Metformin is first-line. If you can't access metformin, the priority is finding a way to access it (telehealth, community health centers, patient assistance programs), not switching to a supplement.

For cost barriers: Generic metformin is available for $4 to $10 per month at Walmart, Kroger, Costco, and Sam's Club pharmacies through their generic prescription programs. Many manufacturers offer patient assistance programs for uninsured patients. Telehealth platforms (including FormBlends) can connect you with a prescriber and pharmacy for lower total cost than an in-person visit.

When supplements make sense and when they don't

The decision tree below is the clearest framework for when OTC supplements are appropriate vs when prescription medication is necessary.

The OTC Supplement Decision Tree:

Start here: Do you have diagnosed diabetes (A1C ≥ 6.5% or fasting glucose ≥ 126 mg/dL)?

• Yes → Prescription medication is necessary. Metformin is first-line. Supplements are not appropriate as monotherapy. If you cannot access metformin, the priority is solving the access problem (see cost-access section above), not substituting a supplement. Contact a provider.

• No → Continue to next question.

Do you have prediabetes (A1C 5.7% to 6.4% or fasting glucose 100 to 125 mg/dL)?

• Yes → Lifestyle intervention (diet, exercise) is first-line. If lifestyle intervention is insufficient after 3 to 6 months, metformin is the evidence-based next step. Berberine is a reasonable alternative if cost or access prevents metformin use, but only with provider awareness. Continue to next question.

• No → You do not have diabetes or prediabetes. Supplements are not indicated for blood sugar control. If you're concerned about blood sugar, get tested (A1C or fasting glucose).

Are you currently taking metformin and experiencing intolerable GI side effects?

• Yes → Try extended-release metformin first (better GI tolerance). If ER metformin is still intolerable, talk to your provider about dose reduction, alternative medications (GLP-1 agonists, SGLT2 inhibitors), or adding berberine as an adjunct. Do not stop metformin and switch to berberine without provider guidance.

• No → Continue to next question.

Are you looking for an adjunct to metformin to improve blood sugar control?

• Yes → Berberine has the strongest evidence as an add-on therapy. Typical dose: 500 mg three times daily with meals. Monitor for GI side effects and drug interactions. Inform your provider. Check A1C after 3 months to assess effectiveness.

• No → Supplements are not indicated.

The summary rule: Supplements are appropriate for prediabetes when lifestyle intervention is insufficient and metformin is inaccessible. They are not appropriate as monotherapy for diagnosed diabetes. They may be appropriate as adjunct therapy to metformin with provider supervision.

What to do if you can't access or afford metformin

If cost or access is preventing you from starting metformin, the following options are available:

Option 1: Generic prescription programs. Walmart, Kroger, Costco, Sam's Club, and most major grocery-store pharmacies offer $4 to $10 per month generic metformin through their prescription savings programs. You need a prescription, but no insurance is required. This is the lowest-cost option for most patients.

Option 2: Telehealth platforms. Platforms like FormBlends connect you with a licensed provider who can prescribe metformin after a virtual consultation. The total cost (consultation + medication) is typically $30 to $60 per month, lower than an in-person provider visit plus pharmacy cost.

Option 3: Community health centers. Federally Qualified Health Centers (FQHCs) provide care on a sliding fee scale based on income. Many offer metformin for $4 to $20 per month for uninsured patients. Find a center near you at findahealthcenter.hrsa.gov.

Option 4: Manufacturer patient assistance programs. While metformin is generic and inexpensive, some manufacturers offer free medication to uninsured patients who meet income requirements. Check needymeds.org or rxassist.org for current programs.

Option 5: GoodRx or other discount cards. Prescription discount cards can reduce the cash price of metformin to $10 to $25 per month at most pharmacies. GoodRx, SingleCare, and RxSaver are free to use.

If none of these options work, berberine is a reasonable stopgap while you work on solving the access problem. But it should not be a permanent substitute for prescription therapy if you have diagnosed diabetes.

The GLP-1 question: are newer medications better alternatives?

For patients who can't tolerate metformin or for whom metformin is insufficient, GLP-1 receptor agonists (semaglutide, tirzepatide) are increasingly prescribed as alternatives or add-on therapy.

GLP-1 medications work through a different mechanism than metformin. They mimic the incretin hormone GLP-1, which:

• Stimulates insulin secretion in response to food
• Suppresses glucagon secretion (reducing hepatic glucose production)
• Slows gastric emptying (reducing post-meal glucose spikes)
• Reduces appetite and food intake (leading to weight loss)

The glucose-lowering effect is stronger than metformin. Semaglutide reduces A1C by 1.5% to 2.0% in clinical trials (Davies et al., Lancet 2021). Tirzepatide (a dual GLP-1/GIP agonist) reduces A1C by 2.0% to 2.5% (Rosenstock et al., New England Journal of Medicine 2021). Both medications also produce significant weight loss (10% to 20% of body weight), which independently improves insulin sensitivity.

The tradeoff is cost and side effects. Brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) cost $900 to $1,300 per month without insurance. Compounded semaglutide and tirzepatide are available through telehealth platforms like FormBlends for $200 to $400 per month, still significantly more expensive than metformin. GI side effects (nausea, vomiting, diarrhea) are common during titration, affecting 40% to 50% of patients.

For patients with type 2 diabetes and obesity, GLP-1 medications are often a better choice than metformin alone. For patients with prediabetes or early diabetes without significant obesity, metformin remains first-line because of its lower cost and decades of safety data.

There is no over-the-counter GLP-1 substitute. Some supplements (berberine, alpha-lipoic acid) are marketed as "natural GLP-1 boosters," but the evidence is weak and the mechanism is indirect. If you're considering GLP-1 therapy, work with a provider to access prescription medication rather than relying on supplements.

The steelman case against OTC substitutes: when you should NOT use supplements

The strongest argument against using OTC supplements as metformin substitutes is this: using a less-effective, less-studied intervention delays evidence-based treatment and increases the risk of diabetes complications.

Diabetes complications (retinopathy, neuropathy, nephropathy, cardiovascular disease) are driven by cumulative glucose exposure over time. Every month you spend with an A1C of 7.5% instead of 6.5% increases your lifetime risk of complications. Metformin reduces that risk. Berberine might reduce that risk, but we don't have the long-term outcome data to know for sure.

The harm is not immediate. It's the slow accumulation of microvascular and macrovascular damage over 5 to 10 years. By the time you realize the supplement wasn't enough, the damage is done.

A thoughtful clinician would argue: if you have diagnosed diabetes, the standard of care is prescription medication. Metformin is inexpensive, well-studied, and effective. If you can't access metformin, the priority is solving the access problem, not substituting a supplement. The access solutions (generic programs, telehealth, community health centers) are available in most of the U.S. The barrier is usually awareness, not availability.

The counterargument is: for patients with prediabetes, lifestyle intervention plus berberine is a reasonable alternative to metformin, especially if the patient prefers to avoid prescription medication. The Diabetes Prevention Program showed lifestyle intervention is more effective than metformin for prediabetes. Adding berberine to lifestyle intervention may provide additional benefit without the need for a prescription.

The line is clear: diagnosed diabetes requires prescription medication. Prediabetes allows more flexibility. If you're unsure which category you're in, get tested and talk to a provider.

FAQ

Is there an over-the-counter substitute for metformin? No true substitute exists. Berberine is the most-studied supplement with blood sugar-lowering effects (1.0% A1C reduction in clinical trials), but it works through different mechanisms than metformin and lacks long-term outcome data. It's not a drop-in replacement.

What is the closest thing to metformin over the counter? Berberine at 500 mg three times daily is the closest in terms of glucose-lowering effect, but it's not equivalent in mechanism, evidence quality, or safety profile. Alpha-lipoic acid, chromium, and cinnamon have weaker evidence.

Can I take berberine instead of metformin? Not if you have diagnosed diabetes (A1C ≥ 6.5%). Metformin is the evidence-based first-line treatment. For prediabetes, berberine is a reasonable alternative if metformin is inaccessible, but lifestyle intervention should be tried first. Always inform your provider.

Does berberine work as well as metformin? In small short-term trials, berberine reduced A1C by approximately 1.0%, similar to metformin. But the evidence base is much smaller (15 to 20 trials vs 300+ for metformin), and there are no long-term cardiovascular outcome studies for berberine.

What are the side effects of berberine? GI side effects (diarrhea, constipation, abdominal pain) occur in 20% to 35% of users, similar to metformin. Berberine also interacts with many medications by inhibiting CYP3A4 and P-glycoprotein, affecting statins, blood thinners, and immunosuppressants.

How much berberine should I take for blood sugar control? The dose used in clinical trials is 500 mg three times daily, taken with meals. Lower doses (500 mg once or twice daily) have not been well-studied and may be less effective.

Can I take berberine and metformin together? Yes, with provider supervision. Some studies suggest additive glucose-lowering effects when combined. Monitor for increased GI side effects and hypoglycemia if you're also taking other diabetes medications.

Does alpha-lipoic acid lower blood sugar? Modestly. Meta-analyses show a 0.3% A1C reduction and 11 mg/dL fasting glucose reduction, much smaller than metformin's effect. It's more promising for diabetic neuropathy than glucose control.

Does chromium help with blood sugar? Only in populations with chromium deficiency. In well-nourished adults (most U.S. patients), chromium supplementation has no significant effect on blood sugar. A 2014 meta-analysis found a 0.5% A1C reduction only in chromium-deficient populations.

Does cinnamon lower blood sugar? The evidence is inconsistent. Some trials show modest fasting glucose reduction (24 mg/dL), but most show no effect on A1C. A 2020 Cochrane review concluded the evidence is too weak to recommend cinnamon for diabetes management.

Why can't I just buy metformin over the counter? Metformin is a prescription medication because it requires medical supervision. Patients need baseline kidney function testing (metformin is contraindicated in kidney disease) and monitoring for rare but serious side effects like lactic acidosis. The prescription requirement ensures appropriate use.

How can I get metformin if I don't have insurance? Generic metformin costs $4 to $10 per month at Walmart, Kroger, Costco, and Sam's Club through their generic prescription programs. Telehealth platforms can connect you with a prescriber for $30 to $60 total cost. Community health centers offer sliding-scale fees.

Are GLP-1 medications better than metformin? For patients with type 2 diabetes and obesity, GLP-1 medications (semaglutide, tirzepatide) are often more effective, reducing A1C by 1.5% to 2.5% and producing 10% to 20% weight loss. But they cost significantly more ($200 to $1,300 per month) and have higher rates of GI side effects.

Can I use supplements if I have prediabetes? Lifestyle intervention (diet, exercise) is first-line for prediabetes and more effective than medication. If lifestyle changes are insufficient after 3 to 6 months, metformin is the evidence-based next step. Berberine is a reasonable alternative if metformin is inaccessible.

What should I do if metformin gives me diarrhea? Try extended-release metformin first (better GI tolerance). If ER metformin is still intolerable, talk to your provider about dose reduction, taking it with food, or switching to an alternative medication. Don't stop metformin and switch to a supplement without provider guidance.

Sources

1. Florez JC et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. Diabetes Care. 2010.
2. Rena G et al. The mechanisms of action of metformin. Diabetologia. 2017.
3. Yin J et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008.
4. Dong H et al. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2015.
5. Guo Y et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Xenobiotica. 2012.
6. Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002.
7. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998.
8. Akbari M et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis. Hormone and Metabolic Research. 2018.
9. Suksomboon N et al. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. Diabetes Technology & Therapeutics. 2014.
10. Allen RW et al. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Annals of Family Medicine. 2013.
11. Zhang Y et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Metabolism. 2008.
12. Davies MJ et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
13. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. New England Journal of Medicine. 2021.
14. Cusi K et al. Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial. Annals of Internal Medicine. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Metformin, Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. GoodRx, SingleCare, and RxSaver are trademarks of their respective companies. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.